These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3019572)

  • 1. Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines.
    Reitnauer PJ; Brown LR; Hank JA; Sondel PM
    Cell Immunol; 1986 Apr; 99(1):196-208. PubMed ID: 3019572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antigen presentation by heat-treated peripheral blood mononuclear cells and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL): heated EBV-LCL present alloantigen and soluble antigen but are deficient in the stimulation of autologous EBV-LCL primed T cells.
    Mandell RB; Hank JA; Chen BP; Robins HI; Sondel PM
    Hum Immunol; 1987 Jul; 19(3):163-77. PubMed ID: 3040644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Chen BP; DeMars R; Sondel PM
    Hum Immunol; 1987 Jan; 18(1):75-91. PubMed ID: 3542914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells.
    Chen M; Shirai M; Liu Z; Arichi T; Takahashi H; Nishioka M
    J Virol; 1998 Oct; 72(10):8301-8. PubMed ID: 9733874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones.
    Livingston PG; Kurane I; Ennis FA
    J Virol Methods; 1997 Aug; 67(1):77-84. PubMed ID: 9274820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B-cell lines as requirement for antigen-presenting cells.
    Vyakarnam A; Lachmann PJ
    Immunology; 1984 Dec; 53(4):601-10. PubMed ID: 6209204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-transformed B cells process and present Mycobacterium tuberculosis particulate antigens to T-cell clones.
    Lombardi G; del Gallo F; Vismara D; Piccolella E; de Martino C; Garzelli C; Puglisi C; Colizzi V
    Cell Immunol; 1987 Jul; 107(2):281-92. PubMed ID: 3036374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-transformed B cell lines present M. leprae antigens to T cells.
    Elferink BG; Ottenhoff TH; de Vries RR
    Scand J Immunol; 1985 Nov; 22(5):585-9. PubMed ID: 3001928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.
    Lee SP; Wallace LE; Mackett M; Arrand JR; Searle PF; Rowe M; Rickinson AB
    Int Immunol; 1993 May; 5(5):451-60. PubMed ID: 8391306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
    J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
    Ramadan G
    Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    Tanaka Y; Sugamura K; Hinuma Y
    J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.
    Zhu F; Ramadan G; Davies B; Margolis DA; Keever-Taylor CA
    Clin Exp Immunol; 2008 Feb; 151(2):284-96. PubMed ID: 18005260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-transformed lymphoblastoid cell lines as antigen-presenting cells and "augmenting" cells for human CMV-specific Th clones.
    Liu YN; Fuad S; Gehrz RC
    Cell Immunol; 1987 Aug; 108(1):64-75. PubMed ID: 3038341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP; DeMars R; Hank JA; Sondel PM
    Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous antigen presentation by autoantigen-transfected Epstein-Barr virus-lymphoblastoid cells. I. Generation of human thyroid peroxidase-reactive T cells and their T cell receptor repertoire.
    Martin A; Magnusson RP; Kendler DL; Concepcion E; Ben-Nun A; Davies TF
    J Clin Invest; 1993 Apr; 91(4):1567-74. PubMed ID: 7682574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.